- Home
- PAHC
as of 02-13-2026 4:00pm EST
$52.26
+$0.99
+1.94%
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
| Founded: | 1946 | Country: | United States |
| Employees: | N/A | City: | TEANECK |
| Market Cap: | 1.7B | IPO Year: | 2014 |
| Target Price: | $34.33 | AVG Volume (30 days): | 297.5K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.26 | EPS Growth: | 373.98 |
| 52 Week Low/High: | $16.16 - $56.30 | Next Earning Date: | 02-04-2026 |
| Revenue: | $1,464,325,000 | Revenue Growth: | 32.39% |
| Revenue Growth (this year): | 15.34% | Revenue Growth (next year): | 3.28% |
| P/E Ratio: | 23.12 | Index: | N/A |
| Free Cash Flow: | 47.3M | FCF Growth: | +208.53% |
AI-Powered PAHC Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 4 days ago
AI Recommendation
hold
Model Accuracy: 75.18%
75.18%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Phibro Animal Health Corporation (PAHC)
BENDHEIM JACK
Sell
President and CEO
PAHC Feb 11, 2026
Avg Cost/Share
$51.91
Shares
14,184
Total Value
$732,185.80
Owned After
50,994
BENDHEIM JACK
Sell
President and CEO
PAHC Feb 10, 2026
Avg Cost/Share
$51.96
Shares
58,014
Total Value
$3,005,525.42
Owned After
50,994
BENDHEIM JACK
Sell
President and CEO
PAHC Feb 5, 2026
Avg Cost/Share
$47.12
Shares
110,842
Total Value
$5,362,103.11
Owned After
50,994
BENDHEIM JACK
Sell
President and CEO
PAHC Feb 4, 2026
Avg Cost/Share
$41.15
Shares
3,520
Total Value
$144,863.49
Owned After
50,994
SEC Form 4
BENDHEIM JACK
Sell
President and CEO
PAHC Feb 3, 2026
Avg Cost/Share
$41.61
Shares
9,660
Total Value
$400,609.67
Owned After
50,994
BENDHEIM JACK
Sell
President and CEO
PAHC Jan 30, 2026
Avg Cost/Share
$40.09
Shares
6,693
Total Value
$268,349.81
Owned After
50,994
SEC Form 4
BENDHEIM JACK
Sell
President and CEO
PAHC Jan 29, 2026
Avg Cost/Share
$40.12
Shares
6,772
Total Value
$271,687.22
Owned After
50,994
SEC Form 4
BENDHEIM JACK
Sell
President and CEO
PAHC Jan 23, 2026
Avg Cost/Share
$40.55
Shares
1,235
Total Value
$50,083.94
Owned After
50,994
SEC Form 4
BENDHEIM JACK
Sell
President and CEO
PAHC Jan 22, 2026
Avg Cost/Share
$42.29
Shares
13,158
Total Value
$552,419.73
Owned After
50,994
BENDHEIM JACK
Sell
President and CEO
PAHC Jan 21, 2026
Avg Cost/Share
$41.68
Shares
14,687
Total Value
$612,127.72
Owned After
50,994
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BENDHEIM JACK | PAHC | President and CEO | Feb 11, 2026 | Sell | $51.91 | 14,184 | $732,185.80 | 50,994 | |
| BENDHEIM JACK | PAHC | President and CEO | Feb 10, 2026 | Sell | $51.96 | 58,014 | $3,005,525.42 | 50,994 | |
| BENDHEIM JACK | PAHC | President and CEO | Feb 5, 2026 | Sell | $47.12 | 110,842 | $5,362,103.11 | 50,994 | |
| BENDHEIM JACK | PAHC | President and CEO | Feb 4, 2026 | Sell | $41.15 | 3,520 | $144,863.49 | 50,994 | |
| BENDHEIM JACK | PAHC | President and CEO | Feb 3, 2026 | Sell | $41.61 | 9,660 | $400,609.67 | 50,994 | |
| BENDHEIM JACK | PAHC | President and CEO | Jan 30, 2026 | Sell | $40.09 | 6,693 | $268,349.81 | 50,994 | |
| BENDHEIM JACK | PAHC | President and CEO | Jan 29, 2026 | Sell | $40.12 | 6,772 | $271,687.22 | 50,994 | |
| BENDHEIM JACK | PAHC | President and CEO | Jan 23, 2026 | Sell | $40.55 | 1,235 | $50,083.94 | 50,994 | |
| BENDHEIM JACK | PAHC | President and CEO | Jan 22, 2026 | Sell | $42.29 | 13,158 | $552,419.73 | 50,994 | |
| BENDHEIM JACK | PAHC | President and CEO | Jan 21, 2026 | Sell | $41.68 | 14,687 | $612,127.72 | 50,994 |
Latest Phibro Animal Health Corporation News
PAHC Breaking Stock News: Dive into PAHC Ticker-Specific Updates for Smart Investing
Compare PAHC vs Leading Stocks
See how PAHC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PAHC Phibro Animal Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.